Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Five Health-Care Stocks That Could Be Good for What Ails You


But make certain to have an exit strategy.

Editor's Note: Chuck LeBeau is the founder of This is his first piece for Minyanville.

With baby boomers creeping closer and closer to retirement -- and the number of uninsured Americans rising -- President Obama lobbied physicians and other health care experts at the annual American Medical Conference in Chicago earlier this week for support for his health-care reform plan.

Many are on the fence about the plan: There's some concern that excess spending could just dig the nation deeper into debt. As for Obama's supporters, they're hopeful that the proposed changes will provide health care to millions of uninsured Americans and improve the inefficiencies of the current program.

Regardless of what happens, the industry will be affected. Here are some companies to take a look at:

1. Johnson & Johnson (JNJ) is up 18% from a March low of $46.60, closing yesterday at $55.20.

2. Merck (MRK) is up 18% from its March low of $20.99, closing yesterday at $24.77.

3. After hitting a March low of $17.96, UnitedHealthGroup (UNH) rebounded yesterday at $24.02, a gain of 33.7%.

4. Medtronic (MDT) is up 32% from its March low of $24.93, closing yesterday at $32.93.

5. WellPoint (WLP) is up nearly 60% from its March low of $30.10, closing yesterday at $48.15.

When investing, it's vital to keep in mind the risks involved in equities and protect yourself with an exit strategy.
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos